Blue Note Therapeutics Product BNT 103 Usability and User Engagement
Sponsored by Blue Note Therapeutics
About this trial
Last updated 3 years ago
Study ID
PROT002 - Test Plan 01 Rev A
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
35 to 55 Years
Female
Not accepting
Healthy Volunteers
Trial Timing
Ended 4 years ago
What is this trial about?
This test aims to explore product development-focused usability and user engagement.
What are the participation requirements?
Inclusion Criteria
- Patient can read, write, and speak in English
- Patient is between the ages of 35-55
- Diagnosed with Stage I-III breast cancer
- In active treatment or within 3 months of ending active treatment and under the care of a clinician at time of study
- Apple mobile phone or tablet user
- Willing to participate in study protocol
Exclusion Criteria
- Any participant not meeting inclusion criteria